1-(2-甲基苯基)乙烯醇 | 107557-18-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-(2-甲基苯基)乙烯醇
• 英文名称: 1-(2-Methylphenyl)ethen-1-ol
• 英文别名: 1-(2-methylphenyl)ethenol
• CAS: 107557-18-6
• 化学式: C₉H₁₀O
• 分子量: 134.17
• InChiKey: FOQUOQOYOHRCJC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• [EN] MODIFIED THIOXANTHONE PHOTOINITIATORS<br/>[FR] PHOTO-INITIATEURS À THIOXANTHONE MODIFIÉS
  申请人：LINTFIELD LTD

  公开号：WO2021144582A1

  公开（公告）日：2021-07-22

  Latent photoinitiator compounds are described, as well as compositions containing such compounds and their uses in photoinitated methods for producing photoresist structured.

  潜在的光引发剂化合物被描述，以及含有这种化合物的组合物，以及它们在生产光阻结构的光引发方法中的用途。
• Multifunctional Type II photoinitiators and curable compositions
  申请人：AGFA Graphics NV

  公开号：EP2130818A1

  公开（公告）日：2009-12-09

  A multifunctional Type II photoinitiator according to Formula (I): wherein X represents a structural moiety according to Formula (II): wherein: A represents a Norrish Type II initiating group; and L represents a divalent linking group positioning the Norrish Type II initiating group A and the CR2R3-group in a 1-5 to a 1-9 position wherein position 1 is defined as the first atom in the aromatic or alicyclic ring of A to which L is covalently bonded and the position 5 to 9 is defined as the carbon atom of the CR2R3-group to which L is covalently bonded, with the proviso that L does not contain an amine. Radiation curable compositions and inks including the multifunctional Type II photoinitiator are also disclosed.

  根据公式(I)，一种多功能的二类光引发剂，其中X代表根据公式(II)的结构基团，其中：A代表Norrish Type II引发基团；L代表二价连接基团，定位Norrish Type II引发基团A和CR2R3基团在1-5到1-9位置，其中位置1被定义为A的芳香环或脂环中与L共价结合的第一个原子，位置5到9被定义为CR2R3基团的碳原子，L与之共价结合，但L不含胺基。还公开了包括这种多功能二类光引发剂的辐射固化组合物和油墨。
• PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
  申请人：Gilead Sciences, Inc.

  公开号：US20150361095A1

  公开（公告）日：2015-12-17

  The present application provides the compounds of formula (J), or pharmaceutically acceptable salts, isomers, or a mixture thereof, wherein n, m, q, A′, W 1 , W 2 , W 3 , R 1 , R 2 , and R 3 are described herein. The compounds are inhibitors to the activities of phosphatidylinositol 3-kinase (PI3K) and are useful for treating conditions mediated by one or more PI3K isoforms. The present application further provides pharmaceutical compositions that include a compound of formula (J), or pharmaceutically acceptable salts, isomers, tautomer, or mixture thereof, and methods of using these compounds and compositions for treating conditions mediated by one or more PI3K isoforms.

  本申请提供了化合物的公式（J），或其药用盐、异构体或其混合物，其中n、m、q、A'、W1、W2、W3、R1、R2和R3如本文所述。这些化合物是磷脂酰肌醇3-激酶（PI3K）活性的抑制剂，可用于治疗由一个或多个PI3K同工型介导的疾病。本申请还提供了包括公式（J）化合物、药用盐、异构体、互变异构体或其混合物的药物组合物，以及使用这些化合物和组合物治疗由一个或多个PI3K同工型介导的疾病的方法。
• AQUEOUS RESIN BASED INKJET INKS
  申请人：AGFA GRAPHICS NV

  公开号：US20170029639A1

  公开（公告）日：2017-02-02

  An inkjet ink includes a) an aqueous medium; and b) capsules composed of a polymeric shell surrounding a core; wherein the capsules are dispersed in the aqueous medium using a dispersing group covalently bonded to the polymeric shell; the core contains one or more chemical reactants capable of forming a reaction product upon application of heat and/or light; the polymeric shell includes a-polymer selected from the group consisting of polyureas, polyesters, polycarbonates, polyamides, and melamine based polymers and copolymers thereof; and the capsules have an average particle size of no more than 4 μm as determined by dynamic laser diffraction.

  一种喷墨墨水包括：a) 水性介质；和 b) 由聚合物壳包围的核心组成的胶囊；其中，使用共价键结合到聚合物壳上的分散基将胶囊分散在水性介质中；核心含有一个或多个化学试剂，能够在加热和/或光照作用下形成反应产物；聚合物壳包括从聚氨酯、聚酯、聚碳酸酯、聚酰胺和三聚氰胺基聚合物及其共聚物组成的α-聚合物；胶囊的平均粒径不超过4μm，通过动态激光衍射确定。
• Antiviral compounds
  申请人：Cai Zhenhong R.

  公开号：US20080076740A1

  公开（公告）日：2008-03-27

  The invention is related to phosphorus substituted anti-viral inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

  该发明涉及磷取代的抗病毒抑制化合物、含有该化合物的组合物、包括给予该化合物的治疗方法，以及用于制备该化合物的有用过程和中间体。